Abouzayed, A., Tano, H., Nagy, Á., Rinne, S. S., Wadeea, F., Kumar, S., . . . Orlova, A. (2020). Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer. Pharmaceutics.
Style de citation ChicagoAbouzayed, Ayman, et al. "Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer." Pharmaceutics 2020.
Style de citation MLAAbouzayed, Ayman, et al. "Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer." Pharmaceutics 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.